Skip to content

The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma

The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05749237
Acronym
PHASTER
Enrollment
100
Registered
2023-03-01
Start date
2023-02-03
Completion date
2023-08-30
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Asthma

Keywords

allergy, asthma, respiratory exercises, children

Brief summary

The goal of this randomized, placebo controlled study is to evaluate the effect of respiratory exercises on asthma attack frequency, symptom and medication scores and quality of life of children with a diagnosis of asthma. Participants will be asked to perform respiratory exercises described at once in hospital at home regularly. Control group will comprised children with asthma without respiratory exercises.

Detailed description

At the beginning of the study anthropometric measurements, basal respiratory function assessment, drugs, demographic information, allergen sensitivity, asthma control levels and quality of life scales will be documented. Patients will be randomly divided into two groups; one group following respiratory exercises and relaxation exercises and the other following only relaxation exercises. Both groups will be called regularly to remind the exercises. The spirometric tests and asthma control forms will be reevaluated at the 3rd and 6th month at hospital. Peak flow meters will be given to patients to document PEF values during study.

Interventions

respiratory exercises

relaxation exercises

Sponsors

Istanbul University - Cerrahpasa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized placebo controlled

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

clinical diagnosis of allergic asthma allergic asthma severity step 1 or step 2 -

Exclusion criteria

asthmatic children more severe than step 2 other comorbid disorders involving respiratory system or neuromusculatory disorders \-

Design outcomes

Primary

MeasureTime frameDescription
Change in asthma attack frequencyat third and sixth monthsasthma attack frequency by home PEF records and questionnaire, spirometric measurements and symptom and medication scoring charts

Secondary

MeasureTime frameDescription
Quality of life questionnaireat third and sixth monthsincrease quality of life

Countries

Turkey (Türkiye)

Contacts

Primary ContactAyca Kiykim
ayca.kiykim@iuc.edu.tr+905423432245

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026